One of the earliest mentions of FABP4 in the context of atherosclerosis dates back to 2002, where FABP4, formerly known as ‘adipocyte lipid binding protein’ (ALBP), ‘adipocyte FABP’ (AFABP), or ‘adipocyte P2’ (aP2), was discovered through a subtractive cDNA library screening in oxidized LDL (oxLDL)-treated and control THP-1 macrophages [14]. This evidence concerns the gene FABP4 and atherosclerosis.